Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease

Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease

US Patent 8664363 · Granted Mar 4, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric antibodies for treatment of amyloid deposition diseases2022
Humanized anti-AXL antibodies2021
Network fieldbus power supply2019
Power supply2018
Humanized anti-Tn-MUC1 antibodies and their conjugates2018
Hepatitis C virus antibodies2015
Humanized antibody compositions and methods for binding lysophosphatidic acid2013
Power supply switching and discontinuous power supply mode2013
Humanized anti-CD22 antibodies and their use in treatment of oncology, transplan2013
Humanized anti-CD22 antibodies and their use in treatment of oncology, transplan2013
Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-42012
Humanized antibodies and compositions for binding sphingosine-1-phosphate2012